No abstract available
MeSH terms
-
Aged
-
Anti-Bacterial Agents / administration & dosage
-
Anti-Bacterial Agents / therapeutic use
-
Antineoplastic Combined Chemotherapy Protocols / adverse effects*
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use
-
Brain Neoplasms / radiotherapy
-
Brain Neoplasms / secondary
-
Carcinoma, Small Cell / complications
-
Carcinoma, Small Cell / drug therapy*
-
Carcinoma, Small Cell / secondary
-
Ceftriaxone / administration & dosage
-
Ceftriaxone / therapeutic use
-
Cisplatin / administration & dosage
-
Combined Modality Therapy
-
Cranial Irradiation
-
Etoposide / administration & dosage
-
Fatal Outcome
-
Female
-
Humans
-
Immunocompromised Host
-
Lung Neoplasms / complications
-
Lung Neoplasms / drug therapy*
-
Opportunistic Infections / complications*
-
Opportunistic Infections / drug therapy
-
Pneumonia, Pneumocystis / complications*
-
Pneumonia, Pneumocystis / drug therapy
-
Pneumonia, Staphylococcal / complications*
-
Pneumonia, Staphylococcal / drug therapy
-
Staphylococcus aureus
-
Trimethoprim, Sulfamethoxazole Drug Combination / administration & dosage
-
Trimethoprim, Sulfamethoxazole Drug Combination / therapeutic use
Substances
-
Anti-Bacterial Agents
-
Etoposide
-
Ceftriaxone
-
Trimethoprim, Sulfamethoxazole Drug Combination
-
Cisplatin